BIST: TRILC
TURK İLAÇ VE SERUM SANAYİ A.Ş.
🌎 Website
Turk Ilac Ve Serum Sanayi Anonim Sirketi, Türkiye'de insan ilaçları ve aşılar üretimi ve satışı yapmaktadır. Aşılar, temel IV çözeltiler, premix çözeltiler, hemodiyaliz çözeltiler, steril distile su, tanı ürünleri ve immünostimülan ürünleri sunulmaktadır.
Ankara
3.70 TRY
TRY3,836,900,000 TRY
USD$84,949,189
EUR—
1 USD = 45.17 TRY
Current Snapshot - 2026 Q1
P/E Ratio
2.97x
↓ vs prior period
P/B Ratio
1.93x
↓ vs prior period
Gross Margin
25.29%
Op. Margin
23.26%
↓ vs prior period
Net Margin
23.26%
↓ vs prior period
ROE
16.26%
↓ vs prior period
ROA
3.82%
Source: KAP
Debt / Equity
3.26x
↑ vs prior period
Current Ratio
0.99x
Liquidity check
Equity Ratio
23.47%
Asset coverage
EV / EBIT
3.70x
↓ vs prior period
Op. profit proxy
EV / Sales
0.86x
↓ vs prior period
Enterprise value
Piotroski F
1/9
Weak (1/9)
Altman Z-Score
1.84
↓ vs prior period
Grey Zone ⚠
Sector Benchmarks KGK — Tümü · 11,069 companies · FY2023 (latest available)
Sector ROE22.0%
Net Margin10.0%
Current Ratio1.17x
Debt/Equity0.73x
Earnings — Q1 2026
Net Income YoY (vs Q1 2025)
▲ +207.3%
323M TRY vs -301M TRY
Revenue YoY (vs Q1 2025)
▲ +116.1%
1.4B TRY vs 643M TRY
Net Income QoQ (vs Q4 2025)
▼ -72.9%
323M TRY vs 1.2B TRY
Revenue QoQ (vs Q4 2025)
▼ -69.4%
1.4B TRY vs 4.5B TRY
Latest KAP Filings
Loading filings...